Collaboration Management. Promptly after the Effective Date, each Party will appoint a person who will oversee day-to-day contact between the Parties for all matters related to the management of the Collaboration Activities in between meetings of the JSC and will have such other responsibilities as the Parties may agree in writing after the Effective Date. One person will be designated by Merck (the “Merck Program Director”) and one person will be designated by Moderna (the “Moderna Program Director,”) together will be the “Program Directors”. Each Party may replace its Program Director at any time by notice in writing to the other Party. Any Program Director may designate a substitute to temporarily perform the functions of that Program Director by written notice to the other Party. The initial Program Directors will be: For Moderna: [***] For Merck: [***]
Collaboration Management. 4.1 To implement, own and manage the Collaboration, Verdant and WindStrip will each designate team members responsible for engineering, design, development, and manufacture of Storage Systems to be integrated into the Integrated Systems.
Collaboration Management. The Parties will manage the collaboration in good faith to (i) conduct the Transfer Plan as efficiently and effectively as possible in order for NBIX to submit an NDA for an Initial Product by the earliest date possible, for (ii) NBIX to develop the Initial Product for all indications in the Field for which it can be demonstrated there is a scientific and commercial justification (subject, in any event, to the provisions of Article 6) and (iii) to, subject to Section 7.2, support labelling designed to ensure the broadest commercial success for the Initial Product.
Collaboration Management. The purpose of the Collaboration management structure set forth below is to coordinate and expedite development and commercialization of Collaboration Products. The activities of the parties under this Agreement shall be managed in this structure only to the extent set forth herein. Each party shall assign individuals from within their respective organizations to each of the following positions. Each party may, in its sole discretion, may replace the assigned individuals at any time as necessary.
Collaboration Management. Each of the Parties shall appoint a single representative to act as that Party’s collaboration manager (each, a “Collaboration Manager”).
Collaboration Management. A joint Steering Committee (Ciba-Chiron-Focal) will manage the research for the Embolization & Fragmentation Study, the First Generation Product Research, and the Radiopharmaceutical Product Research. The committee will periodically review the project plans and resource requirements and make revisions as necessary. Focal will define and manage it's internal resource to meet the goals described in this plan: A Steering committee composed of Ciba and Focal representative will manage the research for the Second Generation Product research with the first drug. The steering committee for the second drug program will be defined once the compound has been identified.
Collaboration Management. 4 2.1 Overview........................................................4 2.2 Joint Research Committee........................................4 2.3 Meetings of the Joint Research Committee........................4 2.4 Functions of the Joint Research Committee.......................5 2.5 Decision-Making of the Joint Research Committee.................5 2.6 Limitations on Joint Research Committee Powers..................5
Collaboration Management. The purpose of the collaboration management structure set forth below is to coordinate and expedite the design, development, manufacture, * Material has been omitted pursuant to a request for confidential treatment, and such material has been filed separately with the SEC.
Collaboration Management. The management structure of the Collaboration will consist of three committees (Annex 1): a “Steering Committee” (STC), a “Scientific Committee” (SC) and a “Developers Committee” (DC). The membership of each of the committees, at the time of signature of this MoU, is given in Annex 2.
Collaboration Management a. Marketing Committee Kos and Xxxxx shall form a marketing committee (the "Marketing Committee"), which shall be responsible for the ongoing management of the collaboration and achievement of the Collaboration Objectives. The Marketing Committee shall be chaired by *******************. The Marketing Committee shall consist of a core membership of three to four representatives from Kos and Xxxxx respectively, including the Marketing or Product Manager from each company. The attendance of AD HOC representatives or invitees may be necessary on a regular or temporary basis. The parties shall bear their own expenses in connection with attending Marketing Committee meetings. The Marketing Committee shall meet periodically, but no less than three (3) times per calendar year, at dates, times and locations mutually agreeable to the parties. Meetings of the Marketing Committee may be conducted in person, or by video- or tele-conference. It is the intention of the Parties that the Marketing Committee shall seek to reach consensus on major issues related to the Marketing Plan and its execution. All marketing disputes shall be resolved by the ******** chairperson. The Marketing Committee shall be responsible for (i) approving the Marketing Plan and financial targets for the Products; (ii) establishing and implementing policies, programs, and procedures; (iii) developing and monitoring the performance metrics related to the Marketing Plan, including without limitation, sales, prescriptions, pricing, expenses, call plan, professional education programs, etc.; and (iv) accounting for all expenses by each party and reporting such information pursuant to the terms of the Agreement. The Marketing Committee shall work diligently to manage all expenses, including the cost of samples, in a cost-effective manner.
